Christopher W. Fulton

Array ( [id] => 6852010 [patent_doc_number] => 20030144213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Combination therapy of angiotensin converting enzyme inhibitor, side-effect reduced amount of aldosterone antagonist and diuretic for treatment of cardiovascular disease' [patent_app_type] => new [patent_app_number] => 10/266432 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7172 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144213.pdf [firstpage_image] =>[orig_patent_app_number] => 10266432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847408 [patent_doc_number] => 20030166575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Compounds which inhibit leukocyte adhesion mediated by VLA-4' [patent_app_type] => new [patent_app_number] => 10/266889 [patent_app_country] => US [patent_app_date] => 2002-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38414 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166575.pdf [firstpage_image] =>[orig_patent_app_number] => 10266889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843613 [patent_doc_number] => 20030148960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Combination therapy of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist for treatment of cardiovascular disease' [patent_app_type] => new [patent_app_number] => 10/264639 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7760 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148960.pdf [firstpage_image] =>[orig_patent_app_number] => 10264639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801593 [patent_doc_number] => 20030096758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'HEPTA-, OCTA- and nonapeptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/263812 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21472 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096758.pdf [firstpage_image] =>[orig_patent_app_number] => 10263812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6762166 [patent_doc_number] => 20030125528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon' [patent_app_type] => new [patent_app_number] => 10/256482 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26646 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125528.pdf [firstpage_image] =>[orig_patent_app_number] => 10256482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 390323 [patent_doc_number] => 07300919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-27 [patent_title] => 'Pulmonary delivery of active fragments of parathyroid hormone' [patent_app_type] => utility [patent_app_number] => 10/245707 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3916 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/300/07300919.pdf [firstpage_image] =>[orig_patent_app_number] => 10245707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783481 [patent_doc_number] => 20030064929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Modulating body/cranial hair growth' [patent_app_type] => new [patent_app_number] => 10/243734 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4167 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064929.pdf [firstpage_image] =>[orig_patent_app_number] => 10243734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851728 [patent_doc_number] => 20060234919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Use' [patent_app_type] => utility [patent_app_number] => 10/488166 [patent_app_country] => US [patent_app_date] => 2002-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12664 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234919.pdf [firstpage_image] =>[orig_patent_app_number] => 10488166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 468211 [patent_doc_number] => 07235627 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Derivatives of GLP-1 analogs' [patent_app_type] => utility [patent_app_number] => 10/285079 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 119018 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235627.pdf [firstpage_image] =>[orig_patent_app_number] => 10285079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668627 [patent_doc_number] => 07094869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Low molecular weight peptidomimetic growth hormone secretagogues' [patent_app_type] => utility [patent_app_number] => 10/224640 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 30 [patent_no_of_words] => 43677 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 517 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094869.pdf [firstpage_image] =>[orig_patent_app_number] => 10224640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6839200 [patent_doc_number] => 20030036540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Betulinol derivatives' [patent_app_type] => new [patent_app_number] => 10/212576 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10001 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036540.pdf [firstpage_image] =>[orig_patent_app_number] => 10212576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814257 [patent_doc_number] => 20030073807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Bi-directional synthesis of oligoguanidine transport agents' [patent_app_type] => new [patent_app_number] => 10/211986 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10757 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073807.pdf [firstpage_image] =>[orig_patent_app_number] => 10211986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232928 [patent_doc_number] => 07598355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto' [patent_app_type] => utility [patent_app_number] => 10/210333 [patent_app_country] => US [patent_app_date] => 2002-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 25 [patent_no_of_words] => 39505 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598355.pdf [firstpage_image] =>[orig_patent_app_number] => 10210333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774825 [patent_doc_number] => 20030018163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Process for the preparation of peptides' [patent_app_type] => new [patent_app_number] => 10/199785 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3007 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018163.pdf [firstpage_image] =>[orig_patent_app_number] => 10199785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721313 [patent_doc_number] => 20030055003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Use of copper chelators to inhibit the inactivation of protein C' [patent_app_type] => new [patent_app_number] => 10/199285 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16010 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055003.pdf [firstpage_image] =>[orig_patent_app_number] => 10199285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721288 [patent_doc_number] => 20030054977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Manufacture of polyglutamate-therapeutic agent conjugates' [patent_app_type] => new [patent_app_number] => 10/198187 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10332 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054977.pdf [firstpage_image] =>[orig_patent_app_number] => 10198187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745848 [patent_doc_number] => 20030023031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents' [patent_app_type] => new [patent_app_number] => 10/196363 [patent_app_country] => US [patent_app_date] => 2002-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10516 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20030023031.pdf [firstpage_image] =>[orig_patent_app_number] => 10196363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070070 [patent_doc_number] => 20050245455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Gonadotropin releasing hormone antagonists in gel-forming concentrations' [patent_app_type] => utility [patent_app_number] => 10/483325 [patent_app_country] => US [patent_app_date] => 2002-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3036 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245455.pdf [firstpage_image] =>[orig_patent_app_number] => 10483325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951441 [patent_doc_number] => 06960646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Cyclic peptides as potent and selective melanocortin-4 receptors agonists' [patent_app_type] => utility [patent_app_number] => 10/483309 [patent_app_country] => US [patent_app_date] => 2002-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3430 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960646.pdf [firstpage_image] =>[orig_patent_app_number] => 10483309 [rel_patent_id] =>[rel_patent_doc_number] =>)